Medroxyprogesterone acetate
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Medroxyprogesterone acetate and local guidelines before prescribing.
Progestogen
Mechanism
Synthetic progestogen.
Uses
Contraception (depot), endometriosis, endometrial protection, palliation.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Irregular bleeding, weight gain, reduced bone density, delayed return of fertility.
Interactions
Enzyme inducers reduce effect.
Contraindications and cautions
Undiagnosed bleeding, breast cancer
Monitoring
Bone density, bleeding
Pregnancy and breastfeeding
Not for use if pregnant
Renal and hepatic impairment
Avoid in severe liver disease
Overdose and reversal
Supportive
Special advice
Review bone health with prolonged depot use.
More from the textbook: uses, cautions and other points
- Medroxyprogesterone acetate | 13-weekly injection; bone density, weight gain, delayed fertility.
Gynaecology: Fertility Contraception Menopause
Where it is discussed in the book
- Gynaecology: Fertility Contraception Menopause (1 mention)